Medilink Therapeutics Gains FDA IND Approval for VEGF-Targeted ADC YL242
Suzhou-based Medilink Therapeutics announced that it has received Investigational New Drug (IND) approval from the...
Zhongsheng Pharma’s Anruiwei Shows Promising Results in Pediatric Influenza A Study
China-based Guangdong Zhongsheng Pharmaceutical Co., Ltd (SHE: 002317) announced the topline analysis data from the...
Sinovac Biotech Gains Hong Kong Approval for Influenza Vaccines
China-based Sinovac Biotech Ltd (NASDAQ: SVA) announced that it has received marketing approvals from the...
InnoCare Pharma Reports 129.92% Revenue Surge in Q1 2025, Turns Profitable
Beijing-based biotech InnoCare Pharma (HKG: 9969, SHA: 688428) released its Q1 2025 financial report, recording...
NMPA Releases 92nd Batch of Reference Drugs for Generic Quality Evaluation
The National Medical Products Administration (NMPA) has released the 92nd batch of reference drugs for...
Gan & Lee Pharmaceuticals Signs PDP Agreement with Brazilian Health Ministry
Gan & Lee Pharmaceuticals (SHA: 603087) announced the signing of Parcerias para o Desenvolvimento Produtivo...
Zelgen Biopharmaceuticals Submits New Indication Application for Jacktinib in Severe Alopecia Areata
China-based Suzhou Zelgen Biopharmaceuticals Co., Ltd (SHA: 688266) announced that it has submitted a new...
Meheco Acquires Golden Harvest for E-commerce Expansion
China Meheco Group Co., Ltd (SHA: 600056) announced the acquisition of 100% stake in Beijing...
JD Healthcare Reports 25.5% Revenue Growth in Q1 2025
JD Healthcare (HKG: 6618), a subsidiary of China’s e-commerce giant JD.com (NASDAQ: JD), released its...
Ocumension Therapeutics Receives Approval for OT-703 Real-World Study in China
Chinese ophthalmology specialist Ocumension Therapeutics (HKG: 1477) announced that it has received approval in China...
Legend Biotech’s Q1 2025 Results Highlight Carvykti Sales Growth
China-based Legend Biotech Corporation (NASDAQ: LEGN) released its Q1 2025 financial report, highlighting significant revenue...
Sanyou Biopharmaceuticals and TransReco Biotechnology Partner to Advance Novel Drug Formulations
China-based Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. and TransReco (Wenzhou) Biotechnology Co., Ltd. announced a strategic...
Novo Nordisk Partners with PingAn Good Doctor to Promote Scientific Weight Loss in China
Denmark-based Novo Nordisk (NYSE: NVO, CPH: NOVO-B) has formed a strategic partnership with China’s Ping...
BRL Medicine Reports Positive Results for TyU19 in Refractory SLE Trial
Shanghai-based BRL Medicine Inc. announced positive results from an investigator-initiated trial (ITT) evaluating its allogeneic...
InnoCare Pharma Partners with Westlake University for Innovative Drug Research
Beijing-based biotech InnoCare Pharma (HKG: 9969, SHA: 688428) announced a strategic partnership agreement with Westlake...
Betta Pharmaceuticals Secures Macau Approval for Ensartinib
China-based Betta Pharmaceuticals (SHE: 300558) announced a market approval filing in Macau for its ensartinib,...
OYMotion Technologies Secures RMB 100 Million in Series B++ Funding for Exoskeleton Robots
Shanghai-based OYMotion Technologies Co., Ltd, a high-tech company specializing in brain-computer interface and robotics technology,...
Genentech to Invest Over $700 Million in North Carolina Drug Manufacturing Facility
Genentech, a member of the Roche Group (SWX: ROG, OTCMKTS: RHHBY), announced plans to invest...
Huadong Medicine Presents DR10624 Study Results for Obesity and Hypertriglyceridemia at EASL 2025
China-based Huadong Medicine Co., Ltd (SHE: 000963) announced the first presentation of results from its...
Teva Announces 8% Workforce Reduction to Achieve $700 Million Cost-Saving Goal
Israel-based Teva Pharmaceutical Industries Ltd (NYSE: TEVA) has disclosed plans to reduce its workforce by...